Faeth Therapeutics focuses on improving cancer treatment by utilizing metabolic optimization to enhance drug targets. The company employs a unique discovery platform called MetabOS that provides insights into drug-nutrient interactions across tumor types.

Faeth Therapeutics

Broad Institute is a multidisciplinary research organization focused on improving human health through the understanding and treatment of disease, self-described as dedicated to better understanding the roots of disease.

Broad Institute

MD Anderson Cancer Center is a cancer treatment and research hospital that focuses on preventing, diagnosing, and treating cancer.

Metric
Company Name	Faeth Therapeutics	Broad Institute	MD Anderson Cancer Center
Symbol
MSH ID	COM:FAETHTHERAPEUTICS	ORG:BROADINSTITUTE	ORG:MDANDERSON
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Research and Development	Healthcare
Country	US	US	US
Stage
Employee Count
Website	faeththerapeutics.com	broadinstitute.org	mdanderson.org
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

FAET

COM:FAETHTHERAPEUTICS

Faeth Therapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue